TRIB - Intrinsic Value and Financial Analysis - Trinity Biotech plc

Trinity Biotech plc TRIB

Healthcare - Medical - Diagnostics & Research - NASDAQ - IE

Watchlist

$ 1.37

-7.43 %

$ 15.6 M

Market Cap

-0.51

P/E

BALANCE SHEET

59.4 M ASSETS

Growth Rates

1Year -35.47%

3Years -23.04%

5Years -17.04%

7Years -18.53%

10Years -12.52%

83.4 M LIABILITIES

Growth Rates

1Year -11.56%

3Years -14.33%

5Years -4.90%

7Years -7.22%

10Years 6.73%

-23.9 M EQUITY

Growth Rates

1Year -1000.60%

3Years -120.99%

5Years -9.07%

7Years -2.88%

10Years -1.24%

BALANCE SHEET DECOMPOSITION

Balance Sheet Decomposition Trinity Biotech plc

59.4 M ASSETS
83.4 M LIABILITIES

Current Assets	39 M
Cash & Short-Term Investments	3.69 M
Receivables	13.4 M
Other Current Assets	22 M
Non-Current Assets	20.4 M
Long-Term Investments	214 K
PP&E	1.89 M
Other Non-Current Assets	18.3 M

Current Liabilities	15 M
Accounts Payable	3.88 M
Short-Term Debt	1.9 M
Other Current Liabilities	9.25 M
Non-Current Liabilities	68.3 M
Long-Term Debt	65.5 M
Other Non-Current Liabilities	2.83 M

Balance Sheet

Millions

	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019	Dec-2018	Dec-2017	Dec-2016	Dec-2015	Dec-2014	Dec-2013	Dec-2012	Dec-2011	Dec-2010	Dec-2009	Dec-2008	Dec-2007	Dec-2006	Dec-2005	Dec-2004	Dec-2003	Dec-2002	Dec-2001	Dec-2000	Dec-1999	Dec-1998	Dec-1997	Dec-1996	Dec-1995	Dec-1994	Feb-1994
ASSETS
Cash & Cash Equivalents	3.7	6.6	25.9	27.3	16.4	30.3	57.6	77.1	102.0	9.1	22.3	74.9	71.1	58.0	6.1	5.2	8.7	2.8	4.9	22.3	20.6	5.8	5.3	4.3	3.1	1.3	2.8	4.9	7.5	0.3	0.9
Short Term Investments	0	0	0	0	1.2	0	34.0	0	0	0	0	0	0	0	0	0	0	0	5.0	0	0	0	0	0	0	100 K	1.4	0	0	0	0
Receivables	13.4	13.4	15.7	24.6	22.4	25.2	21.3	20.2	20.7	21.5	21.6	13.8	22.7	12.6	21.4	27.7	24.8	30.0	19.5	11.8	12.1	10.8	5.7	8.0	7.2	6.7	7.9	3.5	0.4	1.0	0.4
Inventory	19.9	22.5	29.1	30.2	32.0	30.4	32.8	32.6	35.1	33.5	29.7	20.8	19.8	17.6	39.2	42.3	44.4	45.6	36.5	37.5	30.6	20.4	16.3	14.4	9.5	10.0	3.7	0.5	0.3	0.3	0.4
Other Current Assets	2.0	4.1	1.9	1.2	0.6	0.8	0.9	3.6	5.5	5.0	3.1	1.0	1.4	13.1	0	0	1.9	19.0	11.0	4.1	1.8	1.9	2.0	0	0	0	1.4	0.8	0	0.4	0.6
Total Current Assets	39.0	46.7	72.7	83.3	71.4	86.7	112.6	133.5	163.2	69.0	76.7	110.5	115.0	101.3	68.4	75.2	79.8	97.4	76.9	75.7	65.0	38.6	29.3	26.7	19.8	18.1	15.8	9.7	8.2	2.0	2.3
PP&E	1.9	5.7	5.9	8.5	9.3	5.4	5.8	13.4	20.7	17.9	13.0	8.9	7.6	6.0	12.2	11.9	26.4	22.3	19.2	15.9	13.7	9.9	6.0	5.5	4.7	8.4	5.8	1.3	0.9	1.0	1.0
Intangible Assets	16.3	22.7	23.4	21.3	31.1	36.8	46.9	61.5	108.7	91.9	75.3	46.3	25.8	19.4	24.8	18.5	60.4	45.2	85.2	57.9	38.9	39.6	40.4	33.8	20.6	17.9	0.4	0	0	100 K	1.7
Goodwill	0	12.5	12.5	12.6	12.6	16.1	17.9	25.8	52.7	53.1	53.3	26.7	19.6	17.8	20.1	20.1	44.5	76.6	0	0	0	0	0	30.3	18.5	15.9	0	0	0	0	0
Long Term Investments	0.2	0.2	0.2	0.4	0.4	0.5	1.0	0.8	5.6	0	0	0	0	0	0	0	0	0	0	0	0	0	1.4	1.3	0	0.6	2.6	0	0	0	0
Other Long Term Assets	43 K	55 K	56 K	64 K	82 K	82 K	(0.3)	77.6 K	(4.6)	1.1	1.2	0.9	0.5	11.6	1.2	0.9	0.9	76 K	61 K	1.3	0.6	1.2	1.4	1.3	0	0.6	2.6	2.4	100 K	0	100 K
Other Assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Assets	59.4	92.1	118.9	130.4	131.1	151.2	192.6	249.6	359.0	242.8	226.5	197.4	171.5	160.9	132.4	129.5	216.0	249.1	184.6	150.8	118.1	89.3	77.0	67.2	45.0	45.0	24.6	13.4	9.2	3.1	4.9
LIABILITIES
Accounts Payable	3.9	6.2	6.8	7.1	7.8	8.1	8.0	9.0	8.3	9.5	8.2	4.5	3.8	11.4	12.8	23.0	8.5	7.8	6.1	3.3	3.5	3.1	1.7	4.3	2.4	2.6	3.8	1.5	0.3	0.5	1.0
Short Term Debt	1.9	1.9	85.3	5.1	2.4	0.4	0.4	0.3	0.3	0	0	0	0.2	0.2	12.6	12.7	15.8	15.3	14.9	10.4	5.6	0	3.8	1.5	4.6	5.0	0.2	0	100 K	100 K	100 K
Other Current Liabilities	8.9	9.1	7.9	9.6	8.9	8.5	12.2	15.8	10.2	11.8	11.9	8.2	7.5	50 K	0.1	77 K	15.9	9.9	10.9	6.5	10.3	15.5	7.2	4.1	7.3	10.5	4.8	1.5	1.3	1.2	0.6
Total Current Liabilities	15.0	17.3	100.5	27.1	19.4	17.6	21.2	25.3	20.1	22.1	21.0	14.0	13.3	12.3	25.6	35.7	43.5	35.9	31.9	20.3	19.4	18.6	12.7	9.9	14.2	18.1	8.8	3.0	1.7	1.8	1.7
Long Term Debt	65.5	70.3	13.9	99.3	99.8	81.9	93.5	93.0	92.6	0	0	3.3	0	0.1	19.3	23.5	26.4	35.6	12.2	12.4	16.6	7.7	6.1	2.3	8.1	6.9	0	0	0	100 K	100 K
Deferred Tax Income	2.3	5.1	4.9	4.9	7.1	7.4	10.8	18.4	24.8	21.4	17.9	10.7	6.8	7.2	8.2	4.4	9.2	9.4	6.7	1.3	0.9	0	0	0	0	0	0	0	0	0	0
Other Liabilities	0.5	1.6	0	1.4	4 K	8.1	2.2	22.6	32.4	23.8	22.5	1.0	10 K	30 K	0	0	0	0.8	0.1	0.8	0.9	0	1.7	0	0	5.4	8.7	(0.2)	0	100 K	0
Total Liabilities	83.4	94.3	119.2	132.6	126.4	107.2	127.4	140.9	145.1	45.9	43.5	28.0	20.2	19.6	53.1	63.6	79.1	81.9	51.0	34.7	37.8	26.4	20.5	12.2	22.3	30.4	17.5	2.8	1.7	1.8	1.8
EQUITY
Common Stock	2.0	2.0	1.2	1.2	1.2	1.2	1.2	1.2	1.2	1.2	1.2	1.1	1.1	1.1	1.1	1.1	1.0	1.0	0.8	0.8	0.7	0.6	0.6	0.6	0.5	0.4	0.4	0	0	0	0
Retained Earnings	(48.6)	(26.7)	12.6	10.6	11.5	24.4	46.2	93.0	202.0	183.4	168.8	159.0	147.5	(20.9)	(87.1)	(99.5)	(22.9)	10.8	6.3	1.0	(4.2)	(9.4)	(14.5)	(15.9)	(20.7)	(25.6)	(5.9)	(8.5)	(8.7)	(7.7)	(4.1)
Other Accumulative Comprehensive Income/Loss	1.0	(5.7)	(5.4)	(5.3)	(24.2)	2.3	1.6	(1.7)	(4.8)	26 K	4.3	4.1	(1.0)	(0.5)	0.4	(34.6)	4.8	3.7	2.3	(6.1)	(3.8)	(4.4)	(5.1)	(5.2)	(4.6)	(4.4)	(8.2)	0	0	0	0
Total Equity	(23.9)	(2.2)	(0.3)	(2.2)	4.7	44.1	65.2	108.7	213.9	197.0	183.0	169.4	151.3	141.3	79.3	65.9	136.8	167.3	133.6	116.1	80.3	62.9	56.5	55.0	22.7	14.6	7.1	10.6	7.5	1.3	3.1
Total Liabilities and Equity	59.4	92.1	118.9	130.4	131.1	151.2	192.6	249.6	359.0	242.8	226.5	197.4	171.5	160.9	132.4	129.5	216.0	249.1	184.6	150.8	118.1	89.3	77.0	67.2	45.0	45.0	24.6	13.4	9.2	3.1	4.9
SHARES OUTSTANDING
Common Shares Outstanding	7.7	6.7	4.2	4.2	4.2	4.2	4.3	4.6	4.6	4.5	4.4	4.3	4.3	4.2	4.2	4.1	3.8	3.3	2.9	3.6	2.8	2.6	2.5	2.3	7.4	6.4	5.5	4.1	3.8	2.5	1.4

Balance Sheet

Premium Plan

Unlimited Plan